Valuation: LivaNova PLC

Market Cap 4.39B 3.86B 3.56B 3.33B 6.23B 415B 6.36B 42.73B 16.53B 204B 16.49B 16.13B 711B P/E 2026 *
28.8x
P/E 2027 * 24.8x
Enterprise Value 4.41B 3.88B 3.57B 3.34B 6.26B 416B 6.39B 42.93B 16.6B 205B 16.57B 16.2B 714B EV / Sales 2026 *
2.93x
EV / Sales 2027 * 2.62x
Free-Float
98.44%
Yield 2026 *
-
Yield 2027 * -
1 day+1.38%
1 week+3.25%
Current month+9.82%
1 month+9.78%
3 months+29.89%
6 months+28.49%
Current year+31.72%
1 week 77.74
Extreme 77.74
82.66
1 month 70.74
Extreme 70.7401
82.66
Current year 56.44
Extreme 56.44
82.66
1 year 41.02
Extreme 41.015
82.66
3 years 32.48
Extreme 32.48
82.66
5 years 32.48
Extreme 32.48
93.89
10 years 32.48
Extreme 32.48
131.54
Manager TitleAgeSince
Chief Executive Officer 53 2024-02-29
Director of Finance/CFO 56 2020-10-30
Investor Relations Contact - 2022-07-31
Director TitleAgeSince
Director/Board Member 69 2015-10-18
Chairman 74 2021-06-08
Director/Board Member 62 2019-06-17
Date Insider Type Main position Quantity % Market Cap.
06-14Fiscal year

Director

10,953 0.0199%
06-14Fiscal year

Director

7,811 0.0142%
06-14Fiscal year

Director

10,953 0.0199%
Change 5-day change 1-year change 3-year change Capi.($)
+1.38%+3.25%+76.08%+66.67% 4.39B
+3.04%+5.36%-32.47%-13.71% 158B
+0.49%+3.05%-6.46%-7.96% 103B
-0.87%-5.43%+51.86%+55.43% 54.49B
+0.87%+3.56%-2.44%+52.90% 55.35B
+2.44%+6.90%-11.77%-40.99% 40.72B
+4.77%+3.71% - - 30.48B
-1.58%-3.62%-21.61%-45.84% 26.91B
+1.81%+7.10%+55.63%-5.57% 24.05B
+0.43%-2.34%-18.17%-4.00% 19.91B
Average +1.23%+0.25%+10.07%+6.33% 51.65B
Weighted average by Cap. +1.44%+0.87%-5.84%+0.30%

Financials

2026 *2027 *
Net sales 1.51B 1.33B 1.22B 1.14B 2.14B 142B 2.18B 14.67B 5.68B 70.19B 5.66B 5.54B 244B 1.61B 1.42B 1.31B 1.22B 2.29B 152B 2.34B 15.7B 6.07B 75.11B 6.06B 5.93B 261B
Net income 146M 129M 119M 111M 208M 13.8B 212M 1.42B 550M 6.81B 549M 537M 23.66B 179M 157M 145M 136M 254M 16.89B 259M 1.74B 673M 8.33B 672M 657M 28.95B
Net Debt 20.06M 17.65M 16.25M 15.21M 28.47M 1.89B 29.04M 195M 75.48M 933M 75.31M 73.66M 3.25B -167M -147M -135M -127M -237M -15.77B -242M -1.63B -629M -7.77B -627M -614M -27.03B
Logo LivaNova PLC
LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, and Neuromodulation. Its Cardiopulmonary segment is engaged in the design, development, manufacture, marketing, and sale of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories. Its Neuromodulation segment is engaged in the design, development, manufacture, marketing, and sale of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). Its principal Neuromodulation product, the VNS Therapy System, consists of an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals.
Employees
3,300
Date Price Change Volume
26-06-25 US$81.05 +1.38% 652,150
26-06-24 US$79.95 +1.61% 822,050
26-06-23 US$78.68 -0.04% 576,237
26-06-22 US$78.71 +0.27% 689,739
26-06-18 US$78.50 0.00% 1,427,477
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
81.05USD
Average target price
81.50USD
Spread / Average Target
+0.56%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. LIVN Stock